XTAECLAB
Market cap28mUSD
Dec 24, Last price
1,212.00ILS
1D
-0.33%
1Q
18.24%
IPO
-32.21%
Name
C-Lab Ltd
Chart & Performance
P/E
5.01
P/S
0.79
EPS
241.92
Div Yield, %
0.00%
Shrs. gr., 5y
109.11%
Rev. gr., 5y
173.94%
Revenues
13.00b
+10,799.13%
Net income
2.05b
+29,275.72%
CFO
594k
-94.87%
Profile
C-Lab Ltd manufactures and sells ARM-based computer-on-module and system-on-module products worldwide. It also offers miniature fanless-PCs for industrial applications; Internet of Things gateways; and single board computers. Its products are embedded in telecommunication systems, automotive devices, gaming systems, medical devices, aerospace and marine systems, laboratory instruments, industrial automation, and other applications. The company was formerly known as CompuLab Ltd. C-Lab Ltd was founded in 1992 and is based in Yokneam Illit, Israel.
Valuation
Title ILS in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
| Income | ||||||||
Revenues | 13,001,900 10,799.13% | 119,293 43.17% | 83,324 -20.83% | |||||
Cost of revenue | 11,088,600 | 1,544,402 | 1,261,337 | |||||
Unusual Expense (Income) | ||||||||
NOPBT | 1,913,300 | (1,425,109) | (1,178,013) | |||||
NOPBT Margin | 14.72% | |||||||
Operating Taxes | 26,100 | (322) | 451 | |||||
Tax Rate | 1.36% | |||||||
NOPAT | 1,887,200 | (1,424,787) | (1,178,464) | |||||
Net income | 2,051,600 29,275.72% | 6,984 493.37% | 1,177 -89.73% | |||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | 1 | |||||||
Long-term debt | ||||||||
Deferred revenue | 1,069 | 869 | ||||||
Other long-term liabilities | 453,800 | 2,998 | 2,894 | |||||
Net debt | (2,145,400) | (21,306) | (7,753) | |||||
| Cash flow | ||||||||
Cash from operating activities | 594 | 11,588 | (4,843) | |||||
CAPEX | (1,413) | (241) | (1,299) | |||||
Cash from investing activities | (1,413) | (241) | 2,174 | |||||
Cash from financing activities | 697 | (4,800) | ||||||
FCF | (4,243,610) | (1,425,027) | (1,185,586) | |||||
| Balance | ||||||||
Cash | 2,145,400 | 21,306 | 7,753 | |||||
Long term investments | ||||||||
Excess cash | 1,495,305 | 15,341 | 3,587 | |||||
Stockholders' equity | 10,999,800 | 87,958 | 74,457 | |||||
Invested Capital | 7,215,195 | 49,253 | 47,202 | |||||
ROIC | 51.96% | |||||||
ROCE | 21.97% | |||||||
| EV | ||||||||
Common stock shares outstanding | 8,478 | 8,480 | 8,480 | |||||
Price | 13.34 -15.73% | 15.83 -17.51% | 19.19 | |||||
Market cap | 113,092 -15.76% | 134,246 -17.51% | 162,740 | |||||
EV | (2,032,308) | 112,940 | 154,987 | |||||
EBITDA | 1,916,286 | (1,422,974) | (1,175,008) | |||||
EV/EBITDA | ||||||||
Interest | 402 | 445 | ||||||
Interest/NOPBT | ||||||||